Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,080 recruiting studies in this area right now.
By phase
- Not applicable4,186
- Phase 2598
- Phase 1409
- Phase 3324
- Phase 4251
- Phase 1/Phase 2246
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer223
- Endometrial Cancer205
- Bladder Cancer186
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence60
Leading sponsors
- Mayo Clinic60
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca38
- University of Colorado, Denver37
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California350
- Alabama153
- Texas119
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado84
- Illinois79
Recruiting studies6,080 total
- NCT05675969Recruiting
Testing tiny blood particles in at-risk early delivery
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
BordeauxAges 18 years+ - NCT06123884RecruitingPhase 2/Phase 3
BAT1308 plus chemotherapy for PD-L1-positive cervical cancer
This clinical trial tests a new combination therapy (BAT1308 plus chemotherapy, with or without Avastin) for women with advanced cervical cancer that is PD-L1-positive and has not been previously treated with systemic therapy. The goal is to see if this combination can shrink tumors or slow disease progression.
Wuhan, HubeiAges 18–70 - NCT06811649Recruiting
Ultrasound vs. traditional epidural placement for labor pain
This study compares two ways of placing an epidural catheter for pain relief during labor. One method uses ultrasound (a type of imaging) to guide the needle, while the other uses the traditional touch-based approach. The goal is to see which is more effective and easier for the patient.
BolognaAges 18–50 - NCT06599528RecruitingPhase 1
Comparing a new hormone injection to Ovidrel in healthy women
This study compares a new injected hormone (SJ04) with a standard one (Ovidrel) to see if they work similarly. It's for healthy women with regular cycles who might need help with fertility treatments.
Suzhou, JiangsuAges 20–40 - NCT06528184Recruiting
Comparing HPV testing methods for cervical cancer screening
This study compares different ways of testing for HPV (the virus that causes cervical cancer) during routine screening at primary care clinics. It aims to see which testing method works best to detect the virus and prevent cancer.
Singapore, SingaporeAges 30–69 - NCT06544941Recruiting
Improving sleep and mental health in new moms
This study compares two types of bassinets to see if one helps mothers sleep better and feel less stressed after childbirth. It is for pregnant women with a military connection who are willing to use a bassinet and give a blood sample.
Colorado Springs, ColoradoAges 18–45 - NCT07422870Recruiting
Registry for granulomatous mastitis
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07419841RecruitingPhase 1
A study of CTX-10726 for certain advanced cancers
This trial tests a new drug called CTX-10726 in people with advanced kidney, liver, stomach, or uterine cancer that has not responded to standard treatments. The goal is to see if the drug is safe and tolerable.
Phoenix, ArizonaAges 18 years+ - NCT07418749RecruitingPhase 3
Testing a new drug for advanced cervical cancer after standard treatments
This trial is testing a new drug called SHR-A2102 against standard chemotherapy for people with advanced cervical cancer that has not responded to platinum-based chemotherapy and an immunotherapy (PD-1 or PD-L1 inhibitor). The goal is to see if the new drug works better and what side effects it may cause.
Guangzhou, GuangdongAges 18 years+ - NCT07424287RecruitingPhase 3
New drug plus BCG vs chemo for BCG-resistant bladder cancer
This trial tests a new combination treatment (SHR-1501 plus BCG) compared to standard chemotherapy for people with bladder cancer that hasn't responded to BCG. The goal is to see if this combination works better at controlling the cancer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07425015Recruiting
24-hour bladder monitoring study
This study uses a new device to measure your bladder function over a full day, helping doctors better understand urinary symptoms. You might be eligible if you need a standard bladder test and do not have certain conditions like frequent infections or nerve-related bladder problems.
New Orleans, LouisianaAges 22 years+ - NCT07419828RecruitingPhase 3
Study of HRS-1780 for chronic kidney disease
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Nanjing, JiangsuAges 18–80 - NCT07421700RecruitingPhase 1/Phase 2
Study of PF-08634404 alone or with enfortumab vedotin for bladder cancer
This trial tests a new drug, PF-08634404, either by itself or together with another drug called enfortumab vedotin, for people with advanced bladder cancer that has spread. The goal is to see if these treatments can shrink tumors or slow the cancer's growth.
Fayetteville, ArkansasAges 18 years+ - NCT07424547RecruitingPhase 1
Study of SYS6043 for advanced or metastatic solid tumors
This trial tests a new study drug (SYS6043) for people with advanced or metastatic solid tumors that have not responded to or are not candidates for standard therapies. The drug targets a protein called B7-H3 on cancer cells to help stop tumor growth.
Plantation, FloridaAges 18 years+ - NCT06816563Recruiting
Predicting success of turning a breech baby
This trial studies a special ultrasound measurement called the 'breech progression angle' to see if it can predict whether a doctor can safely turn a breech baby into a head-down position using gentle pressure on the belly (external cephalic version).
Bologna, BolognaAges 18–45 - NCT04799912Recruiting
Start labor at 39 weeks to reduce C-sections
This study compares two plans for first-time mothers: inducing labor at 39 weeks versus waiting for labor to start on its own. It aims to see whether induction lowers the chance of needing a C-section in low-risk pregnancies.
BordeauxAges 18 years+ - NCT07423793Recruiting
Tele-Supported Motor Imagery Exercise for High-Risk Pregnancy
This trial tests a home-based program where you mentally practice gentle movements (motor imagery) to stay active even when bed rest is needed. It's designed for pregnant women with certain high-risk conditions who cannot do physical exercise.
IzmirAges 18–45 - NCT07424846RecruitingPhase 2/Phase 3
Xylitol gum to prevent gum disease and early birth
This trial tests if chewing xylitol gum during pregnancy can reduce gum disease and preterm birth. You would chew gum after meals and attend dental visits and follow-ups.
LilongweAges Any age - NCT07424560Recruiting
Bladder Cancer DNA Testing Study
This study looks for specific DNA changes in bladder cancer tumors using a precise test. It aims to better understand the disease and may help guide future treatment choices.
Lanzhou, GansuAges 18 years+ - NCT07422506Recruiting
Comparing treatments for early missed abortion
This study compares different treatment methods for early missed abortion (when a pregnancy ends but the tissue doesn't pass on its own) to see which works best in real-world settings. It may help you and your doctor choose the safest and most effective option.
Changsha, HunanAges 18–40 - NCT07417228Recruiting
Exercise program for menopause symptoms
This study tests a combined aerobic and resistance training program for women going through menopause. The goal is to see if this type of exercise can help manage symptoms like irregular periods and other changes during this time.
Dublin, DublinAges 40–60 - NCT07420127RecruitingPhase 4
Comparing two doses of a blood pressure drug during c-section
This trial tests two different doses of phenylephrine, a medicine used to manage blood pressure, in women having a planned cesarean section. It aims to see how each dose affects a common drug given to help the uterus contract after birth.
Rawalpindi, Punjab ProvinceAges 20–40 - NCT07422181Recruiting
Ultrasound to see uterine blood vessels after birth
This study tests whether a special ultrasound with contrast dye can help doctors see the small blood vessels in the uterus right after birth. It may improve understanding of the uterus and help prevent bleeding.
VeldhovenAges 18 years+ - NCT07421895Recruiting
Study on retained tissue after pregnancy
This study follows patients with retained products of conception (tissue left in the uterus after a pregnancy) to see how they are managed in real-world medical practice. You may join if an ultrasound shows a tissue area of at least half a centimeter.
Changsha, HunanAges 18–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,080 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,829 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.